Last updated on August 2019

An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers

Brief description of study

The purpose of this study is to determine the efficacy and safety of investigational drug relatlimab plus nivolumab in combination with chemotherapy in participants with unresectable, untreated, locally advanced or metastatic gastric or GEJ cancer.

Clinical Study Identifier: NCT03662659

Find a site near you

Start Over

Local Institution

San Juan, Puerto Rico
  Connect »